Development of Fluid Intake App for Management of Fluid Intake During Hemodialysis , Full Scale Trial

Not Applicable

Completed

Brief Summary: Methods are needed to help decrease interdialytic weight gains in hemodialysis patients. One potential method for accomplishing this goal is to develop an app for smartphones that allow patients to track their fluid intake throughout the course of the day. NCT 03759847 was designed to test the safety and efficacy of this app. In this protocol, part of the same IRB number, patients with large interdialytic fluid gains (3.5% or greater) will use the app to to determine the association between the interdialytic weight gain and the fluid consumed as recorded by use of the app for each interdialytic period.

Detailed Description: In this full scale study, the app will be used to try and influence fluid intake behavior in those patients who are identified to have large fluid weight gains, as defined by a greater than 4% increase in interdialytic weight.

There will be two parts to the full scale trial. In the first part of the full scale study, denoted as the active phase, which will last for two months, study participants will be encouraged to use the app on a daily basis and will meet with the study coordinator on weeks 1, 2, 4, 6, and 8 to further assist the participant in decreasing fluid intake between dialysis sessions. In the second portion of the study, denoted as the passive phase, which will last for six months, the patient will use the app and meet with the study coordinator only when requested by the patient. The number of these sessions will be recorded. At the end of the six month passive phase, the participant will meet for the last time with the study coordinator. During each study visit, subjects will be asked to transfer the data from the App to the study coordinator via the data export function of the app.

Recruitment & Eligibility

Inclusion Criteria

Subject, upon briefing of the content of the present study, fully understanding and agreeing to its objective and having given written (dated and signed) informed consent form to take part in the study.
Adult chronic hemodialysis patient who is at least 18 years of age
Average interdialytic fluid gains of 3.5% or greater of body weight for both weekdays and weekends for a 30 day period
Availability of interdialytic weight gains for the 2 month period prior to enrollment into the study
Access to a smartphone for use of the app and comfort with using apps on a regular basis
Access to a smartphone running under either iOS or Android operating systems
Sufficient knowledge and understanding of the English language to use the application available only in English (US) language
Mental capacity to use and understand the fluid management app
Willingness to share intake data collected with the research team

Exclusion Criteria

Scheduled for a living related renal transplant in the next seven months
Hospitalization within 30 days of entry into the study
Current participation in a randomized clinical trial or in the exclusion period of another clinical trial
Vulnerable subjects defined as individuals whose willingness to volunteer in the clinical trial may be unduly influenced by the expectation, whether justified or not, of benefits associated with participation, or of a retaliatory response from senior members of a hierarchy in case of refusal to participate.

Arm && Interventions

Group	Intervention	Description
Fluid intake app	Fluid intake app	Participants in this arm will use the fluid intake app to help them decrease interdialytic fluid intake. Participants will take a survey to assess the efficacy of the fluid app..

Primary Outcome Measures

Name	Time	Method
Mean intradialytic weight gain	between baseline (pre-app) and the Passive phase (month 3-8)	Comparison of interdialytic weight change before and during use of the app

Secondary Outcome Measures

Name	Time	Method
Mean intradialytic weight gain	between baseline (pre-app) and the Active phase (months 1 and 2), between baseline (pre-app) and the Passive phase (month 3-8)
25th percentile of intradialytic weight gain	between baseline (pre-app) and the Active phase (months 1 and 2), between baseline (pre-app) and the Passive phase (month 3-8)
75th percentile of intradialytic weight gain	between baseline (pre-app) and the Active phase (months 1 and 2), between baseline (pre-app) and the Passive phase (month 3-8)
Number of days of app usage	the Active phase (months 1 and 2), Passive phase (month 3 through month 8)
Percentage of days of app usage	the Active phase (months 1 and 2), Passive phase (month 3 through month 8)
Number of patients who experienced at least 50% increase in fluid intake during app use	the Active phase (months 1 and 2), Passive phase (month 3 through month 8)	Safety evaluation.

Locations (1): Wake Forest School of Medicine
🇺🇸
Winston-Salem, North Carolina, United States